Brief: Adamis Pharmaceuticals Announces Reverse Stock Split
19/05/2023 17:01
May 19 (Reuters) - Adamis Pharmaceuticals Corp ADMP.O :
* ADAMIS PHARMACEUTICALS ANNOUNCES REVERSE STOCK SPLIT
* ADAMIS PHARMACEUTICALS CORP- WILL EFFECT A 1-FOR-70
REVERSE
STOCK SPLIT OF ITS COMMON STOCK THAT WILL BECOME EFFECTIVE ON
MAY 22, 2023
Source text for Eikon: ID:nGNX1T73JZ
Further company coverage: ADMP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on DMK Pharmaceuticals
See all newsBrief: Dmk Pharmaceuticals Corp Says Ebrahim Versi Resigned As Chairman
Brief: ZMI Pharma Finalized Acquisition Of All Strategic Assets Necessary To Manufacture Zimhi From Dmk Pharma
Brief: DMK Pharmaceuticals Files For Chapter 11 Bankruptcy In The U.S. - Court Filing
Brief: Dmk Pharmaceuticals Regains Full Rights To Commercialize Zimhi
Brief: DMK Pharmaceuticals Regains Full Rights From US Worldmeds For Symjepi And Provides Corporate Update